Albertini David F
Center for Human Reproduction, c/o Ovistagen LLC, 233 Beach Road, Unit C2, Salisbury, MA 01952, USA. Email:
Reprod Fertil Dev. 2019 Jan;32(2):7-10. doi: 10.1071/RD19271.
Procuring high-quality oocytes is the rate-limiting step for assisted reproduction technologies intended for embryo production. Although much is known about the intraovarian processes that dictate oocyte growth and maturation, subtleties in the process of oogenesis have yet to be replicated in invitro systems. In contrast with the mouse, in which functional oocytes have been derived from stem cells under ex vivo conditions, the generation of developmentally competent oocytes in other species has yet to be achieved. This paper reviews the principles and practices based on stem cell and organ culture strategies that hold promise for developing a technological base upon which future efforts to recapitulate or augment oogenesis in mammals could be realised.
获取高质量的卵母细胞是用于胚胎生产的辅助生殖技术的限速步骤。尽管对于决定卵母细胞生长和成熟的卵巢内过程已经有了很多了解,但卵母细胞发生过程中的微妙之处尚未在体外系统中得到复制。与小鼠不同,在小鼠中已在离体条件下从干细胞获得了功能性卵母细胞,而在其他物种中尚未实现具有发育能力的卵母细胞的生成。本文综述了基于干细胞和器官培养策略的原理和实践,这些策略有望为开发一个技术基础,在此基础上未来有可能实现哺乳动物卵母细胞发生的重现或增强。